Company news
Psyence Group Inc. news in 2024
Psyence Group Inc.'s news releases, calls and decks from 2024, newest first.
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations
December 6, 2024
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
October 31, 2024
Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical
October 14, 2024
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
September 20, 2024
Psyence Group: NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
May 6, 2024
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
March 26, 2024